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Retrospective Evaluation of the Influence of
the Interleukin-1 Genotype on Radiographic
Bone Levels in Treated Periodontal
Patients Over 10 Years
Marcello Cattabriga,* Roberto Rotundo,† Leonardo Muzzi,† Michele Nieri,‡ Guerina Verrocchi,*
Francesco Cairo,† and Giovanpaolo Pini Prato†
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Background: A difference in genetic susceptibility to plaque accumulation
has been advocated to explain different responses to periodontal therapy.
The purpose of this study is to assess the role of the interleukin-1(IL-1) poly-
morphism on the rate of bone and tooth loss in non-smoking periodontally
treated patients during maintenance.
Methods: Sixty consecutive non-smoking patients (mean age 46.8 ± 5.0)
with moderate to severe periodontitis, treated and maintained for over 10
years were selected. At baseline (T0), radiographic evaluation (cemento-
enamel junction [CEJ]-root apex, CEJ-bottom of defect mesial and distal,
CEJ-bone crest mesial and distal, crown-root ratio) was performed. All
patients received scaling and root planing; 36 patients then underwent sur-
gical therapy. Subsequently, all patients were enrolled in a periodontal main-
tenance program with recall visits every 3.4 ± 1.0 months for at least 10
years. At the latest recall visit (T2) the same radiographic measurements eval-
uated at baseline were taken and a DNA sample for IL-1 genetic suscepti-
bility testing was collected and sent for analysis.
Results: Twenty-three of the 60 patients (38.3%) were IL-1 genotype pos-
itive. A total of 52 teeth (3.3%) out of 1,566 were lost due to periodontitis
between T0 and T2; 28 of 957 (2.9%) in the IL-1 genotype negative group
and 24 of 609 (3.9%) in IL-1 genotype positive group. The mean variation
in bone defect level (∆BD) averaged −0.04 mm in IL-1 genotype negative
patients and 0.01 mm in IL-1 genotype positive patients. The mean varia-
tion in bone crest level (∆BC) averaged −0.24 mm in IL-1 genotype nega-
tive patients and −0.28 mm in IL-1 genotype positive patients. However, a
few patients showed significant differences in response to therapy based on
initial bone levels and genotype. IL-1 negative patients who showed minimal
initial bone loss responded to the therapy better than the IL-1 positive patients.
IL-1 positive patients with severe initial bone loss showed a better response
to the therapy than IL-1 negative patients.
Conclusions: On average, there were no significant differences related to
IL-1 genotype in tooth loss after 10 years in a non-smoking, well-maintained
periodontal population. On an individual patient basis, the IL-1 genotype, in
combination with the initial bone level, seems useful at the beginning of ther-
apy for predicting bone level variation. J Periodontol 2001;72:767-773.
KEY WORDS
Periodontal diseases/therapy; interleukin-1; bone loss/etiology; tooth
loss/etiology; disease susceptibility.
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Many studies have doc-umented that peri-odontitis can be suc-
cessfully treated provided good
plaque control is achieved.
However, not all sites or
patients respond similarly to
therapy. In long-term studies, a
small percentage of patients
have continued to break down
leading to increased tooth
loss.1
Different responses to
plaque accumulation based on
differences in genetic suscep-
tibility have been advocated to
explain this variation.
Recently a genetic test§ has
been developed to identify a
specific genotype in the IL-1
gene cluster. Patients testing
genotype positive produce
increased levels of interleukin-
1 in response to an inflamma-
tory stimulus. The increased
production of this inflamma-
tory mediator can lead to
increased destruction of peri-
odontal tissues following
plaque accumulation. It has
been calculated that 29.1% of
Caucasian Northern European
subjects are IL-1 genotype
§ PST, Interleukin Genetics, Waltham, MA.
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positive and, for this reason, this group of patients
should be considered at major risk to develop severe
periodontal disease.2
In the Kornman et al. cross-sectional study,2 the IL-
1 genotype in non-smoking patients between the ages
of 40 and 60 was strongly related to severe periodon-
titis with an odds ratio of 18.90 (severe versus mild
periodontitis). In smokers, however, severe disease
was not correlated with the IL-1 genotype, confirming
the importance of smoking alone as an important risk
factor.2
A recent longitudinal retrospective evaluation by
McGuire and Nunn3 has confirmed the important role
of smoking and a positive IL-1 genotype in relation to
tooth loss in a group of patients who have been in
maintenance care for 14 years. The authors showed
that a positive IL-1 genotype increased the risk of tooth
loss by 2.7 times, heavy smoking by 2.9 times, and
the combined effect of positive IL-1 genotype and
heavy smoking by 7.7 times.
These studies indicate that not only is there an asso-
ciation between IL-1 genotype positive patients and
severe periodontal disease, but also that tooth mor-
tality rate is higher in this group of patients even after
treatment and appropriate maintenance.
The objective of this investigation is to evaluate if
the IL-1 genotype impacts radiographic bone levels
and tooth loss in non-smoking patients, aged 40 to
60, following treatment and long-term periodontal
maintenance.
MATERIALS AND METHODS
The study population consisted of 60 patients con-
secutively selected by a single clinician in a single pri-
vate periodontal practice during a routine periodon-
tal maintenance visit (PMV). Patients had to satisfy
the following criteria: 1) moderate to severe peri-
odontitis prior to treatment with the presence of at
least 15 teeth, excluding third molars; 2) previous peri-
odontal treatment; 3) 40 to 60 years old at the begin-
ning of therapy; 4) non-smoker for at least 5 years
prior to treatment and throughout subsequent years
of maintenance; 5) negative medical history; and 6)
in periodontal maintenance for at least 10 years.
Patients included 29 males (48%) and 31 females
(52%), of Caucasian heritage, from the middle eco-
nomic levels and a mean age of 46.8 ± 5.0 years
(range 40 to 58) at the beginning of treatment. All
subjects were treated and maintained for at least 10
years (12.7 ± 2.2 years, mean ± SD) between 1980
and 1999.
Treatment
The same operator, with more than 10 years of expe-
rience, treated patients in the same private practice
limited to periodontics.
At the baseline (T0), all patients were clinically and
radiographically evaluated and thoroughly instructed
in proper oral hygiene methods (modified Bass tech-
nique and interproximal cleaning procedures). Sub-
jects were treated with full-mouth scaling and root
planning under local anesthesia in 4 appointments.
Five to 7 weeks after initial treatment, patients were
clinically re-evaluated (T1).
Based on clinical judgment and the nature of the
periodontal defect, 36 subjects were subsequently
treated surgically with modified Widman flap or resec-
tive surgery. During the PMV phase, subgingival instru-
mentation was performed under local anesthesia at
specific sites if bleeding on probing was evident at a
recall appointment. If bleeding on probing was still pre-
sent at the following recall visit or there was a nega-
tive change in probing depth or x-rays evaluation,
surgery was scheduled.
All subjects participated in a stringent PMV pro-
gram. At each recall appointment (mean ± SD, 3.4 ±
1.0 months), they received a full-mouth professional
prophylaxis and localized subgingival instrumentation
as needed. Oral hygiene procedures (including inter-
proximal cleaning) and patient compliance were rein-
forced each visit. Probing depths were recorded every
year and an x-ray examination performed every 3
years.
After 10 years minimum of PMV (T2), the subjects
were clinically and radiographically re-evaluated. Dur-
ing this maintenance period, any additional prosthetic,
endodontic, and restorative treatments or tooth extrac-
tions were performed by different operators in con-
sultation with the periodontist.
Clinical Evaluation
At the T0 and T2, a dental examination recording the
number of missing teeth, restorations, and x-ray sta-
tus was performed. No third molars were included in
this study. In addition, at the T2 appointment, a finger-
stick blood sample was collected and submitted for
IL-1 genotype analysis. Each subject’s finger was
cleaned with an antiseptic wipe and the skin was punc-
tured with a sterile lancet to collect blood droplets on
a DNAase-free blotting paper and sent for blinded
analysis to the genetic testing laboratory. The results
of the test (genotype positive or negative) were not
revealed until all the clinical and radiographic evalu-
ations were complete (T2).
Radiographic Evaluation
For the purpose of this study, T0 and T2 intra-oral
radiographs were analyzed. The radiographs were
obtained with a film holder¶ using the long-cone tech-
nique. Radiographs were placed on a diaphanoscope
768
 Ultra-speed DF 58, Eastman Kodak Company, Rochester, NY.
¶ Rinn XCP, Rinn Corporation, Elgin, IL.
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without any magnification and a millimeter ruler used
directly on the films to obtain the linear measurements
(to the next mm). Two operators evaluated all radi-
ographic measurements. The measurement criteria
were based on standardized reference points and on a
tooth referring axis (Fig. 1).
The referral points were the cemento-enamel junc-
tion (CEJ), both mesial and distal, and the root apex
(RA). Mesial and distal measurements for lower molars
were obtained by using the median point of the con-
junction line of the 2 apices of the mesial and distal
roots. For the upper molars, the apex of palatal root
for both the mesial and distal measurements was used.
For upper and lower single rooted teeth, the unique
apex was used. The bone defect (BD) was the deep-
est point of the defect, mesial and distal and the bone
crest (BC), the most coronal point, mesial and distal.
On single-rooted teeth, the referral axis was obtained
by connecting the root apex point with the median
point of CEJmes-CEJdist line. On lower molars, the
axis was obtained by connecting the median point of
the apex line with the median point of CEJmes-CEJdist
line. On upper molars, the axis was obtained con-
necting the apex point of palatal root with the median
point of CEJmes-CEJdist line.
The following measurements were taken by pro-
jecting these referral points on the main axis and mea-
suring the following distances: 1) CEJ-RA (mesial and
distal); 2) CEJ-BD (mesial and distal); and 3) CEJ-
BC (mesial and distal).
If the reference points were not detectable on the x-
ray film, due to the overlapping of images or points out
of film view, the respective measurements at the miss-
ing point were excluded. When the CEJ point was not
detectable because of a restoration (filling or prosthetic
crown), the margin of that restoration was used as the
reference point.
Statistical Analysis
The reliability of the radiographic measurements was
evaluated with a preliminary intra- and inter-examiner
reliability study by evaluating the same measurement
of the same radiograph at 2 different times. Intra-class
correlation coefficients (R), considering raters fixed,
were determined for: 1) the reproducibility of mea-
surements made by each observer; and 2) the mea-
surements made by one observer versus the other. The
measurements evaluated were CEJ-RA mesial and dis-
tal, CEJ-BD mesial and distal, and CEJ-BC mesial
and distal. The number of analyzed random sites was
approximately 50 for each variable.4,5 An important
inferential question was whether the rater effects dif-
fer significantly from one another.
Descriptive analysis was performed on the inde-
pendent variable data for all the available sites aver-
aged for each patient. Means at baseline were evalu-
ated for both IL-1 genotype negative and positive
patients and compared using the t-test, Wilcoxon test,
or Fisher exact test according to the variable analyzed.
The measurements recorded at T2 were related to
the root length in order to correct, as much as possi-
ble, errors due to projection of the mesial as to distal
sites. The following equations were used:
































Two statistical analyses were performed on the
means for ∆BD and ∆BC for the IL-1 genotype nega-
tive and positive patients to evaluate differences in
therapy effectiveness by genotype.
Teeth lost during the study, teeth with mesial or dis-
tal CEJ-RA differences ≥5 mm between T0 and T2,
teeth restored during the maintenance phase, teeth
with renewed restorations, and teeth for which it was
impossible to measure CEJ-RA or CEJ-BD were
excluded from the statistical analysis performed on
∆BD. Similar exclusion criteria were considered for
∆BC analysis. Patients with at least 20 measurable
sites were included in the analysis. The remaining sites
were analyzed for IL-1 genotype negative and positive
groups. All sites for the patient were averaged so that
the analysis was conducted at the patient level.
A t-test was used to compare the 2 genotype groups
at baseline. An analysis of covariance (ANCOVA) was
used on the ∆BD and ∆BC values, correcting for the
baseline BD and BC values, respectively. The ANCOVA
model included a test for heterogeneity of slopes (a
test of the hypothesis of parallel regression lines). If
the lines were parallel, then a test for group differ-
ences would have been performed. Since the lines were
not parallel, the Potthoff extension of the Johnson-
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Figure 1.
Radiographic evaluation technique.The measurements were taken
reporting the projection of the referral points on the main axis.
A: referral axis; CEJ: cemento-enamel junction; BC: bone crest;
BD: bone defect; RA: root apex.
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Neyman procedure6-10 was used. This procedure pro-
vides regions of significance where the groups are dif-
ferent, depending on the baseline covariate.
RESULTS
Preliminary study results concerning variables mesial
CEJ-RA, distal CEJ-RA, mesial CEJ-BD, distal CEJ-
BD, mesial CEJ-BC, and distal CEJ-BC did not show
a significant interexaminer reliability difference (α =
0.05) and the intra-class correlation coefficients (R)
were all >0.85 (Table 1).
Results of the genetic test indicated 23 patients were
IL-1 genotype positive (38.3%) and 37 negative
(61.7%). Descriptive statistical analysis data are shown
in Table 2.
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As for tooth loss, 52 teeth (3.3%) out of 1,566 were
lost due to periodontitis between baseline and T2: IL-
1 genotype negative patients lost 28 teeth (2.9%) out
of 957 present at T0 (an average of 0.76 teeth for
patient) and IL-1 positive patients lost 24 teeth (3.9%)
out of 609 present at T0 (an average of 1.04 teeth for
patient). These differences were not statistically sig-
nificant. Over half of the patients (36/60) had subse-
quent surgical procedures performed during the main-
tenance period. Of these, 22 were from the genotype
negative group (22/37 or 59.5%) and 14 from the
genotype positive group (14/23 or 60.9%). The aver-
age number of surgically treated teeth per patient was
7.00 for genotype negative patients and 7.96 for geno-
type positive patients. The differ-
ence was not statistically signifi-
cant (P = 0.6936).
At the beginning of therapy
1,566 teeth (3,132 sites) were orig-
inally present. Subsequently 189
teeth were excluded. The remaining
1,377 teeth (2,754 sites) were
included in the analysis (Table 3).
Two IL-1 negative patients were
excluded because they had less
than 20 sites radiographically
detectable.
From the ∆BD calculation, 362
sites were excluded and the remaining 2,392
sites were then averaged for patient. For the
∆BC calculation, 365 sites were excluded
and the remaining 2,389 sites were then
averaged for patient. The average number
of sites per patient used for ∆BD and ∆BC
analysis is shown in Table 4.
The results for ∆BD (averaged for patient)
in the IL-1 genotype negative group were
−0.04 mm ± 0.46 and 0.01 mm ± 0.61 for
the IL-1 genotype positive group. The results
for ∆BC (averaged for patient) were −0.24
mm ± 0.49 for the IL-1 genotype negative
group and −0.28 mm ± 0.36 for the IL-1
genotype positive group.
The 2 tests of hypothesis of parallel
regression lines are statistically significant
(IL-1 genotype × CEJ-BDT0 interaction: P
value = 0.0051; IL-1 genotype × CEJ-BCT0
interaction: P value = 0.0054). Since the
slopes of regression were unparallel, Pot-
thoff’s technique has been applied. The
lower boundary (XL) and upper boundary
(XU) of the region of non-significance were
identified (Table 5). A scatter plot with the
regression lines of the 2 genotype groups
for ∆BD and ∆BC in relation to the baseline
CEJ-BD and CEJ-BC values is shown in
770
Table 1.
Results of Preliminary Intra- and Interexaminer Reliability
Study
CEJ-RAmes CEJ-RAdis CEJ-BDmes CEJ-BDdis CEJ-BCmes CEJ-BCdis
Examiner 1 0.98 0.97 0.99 0.99 0.99 0.98
Examiner 2 0.86 0.90 0.95 0.95 0.96 0.89
Interexaminer 0.90 0.94 0.97 0.92 0.96 0.92
Table 2.
Descriptive Statistical Analysis (data averaged on all
valuable sites; mean  SD)
IL-1 Negative IL-1 Positive
N = 37 N = 23 P
Age 46.03 ± 4.21 47.96 ± 5.88 0.1442 (t test)
(40-53)* (40-58)
N = females 18 13 0.6033 (Fisher exact test)
T0 teeth 25.86 ± 2.49 26.48 ± 1.88 0.4667 (Wilcoxon test)
(17-28) (21-28)
Tooth loss 0.76 ± 0.93 1.04 ± 1.15 0.3565 (Wilcoxon test)
(due to periodontitis) (0-3) (0-4)
T0 restored teeth 2.19 ± 2.93 1.43 ± 2.04 0.2846 (t test)
(0-11) (0-7)
Surgically treated teeth 7.00 ± 8.79 7.96 ± 9.58 0.6936 (t test)
(0-28) (0-26)
CEJ-RAT0 (mm) 15.71 ± 1.50 15.96 ± 1.32 0.5144 (t test)
(13.27-18.76) (13.96-18.90)
CEJ-BDT0 (mm) 4.17 ± 1.21 4.23 ± 1.23 0.8454 (t test)
(1.37-6.76) (2.38-6.43)
CEJ-BCT0 (mm) 3.37 ± 1.05 3.22 ± 0.99 0.5842 (t test)
(1.17-6.09) (1.71-5.11)
* Minimum to maximum values.
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Figures 2 and 3, respectively. The covariate values
within the range XL-XU were not statistically significant
between positive and negative IL-1 genotype patients.
However, as evident from the ∆BD scatter plot (Fig.
2), of the 23 patients who were IL-1 genotype positive,
there were only 3 above the 5.81 cut-off value. Of the
35 patients who were IL-1 genotype negative, there
was 1 patient above the upper boundary and 1 patient
below the lower boundary of the region of non-signif-
icance. As for the ∆BC scatter plot (Fig. 3), 2 IL-1
genotype positive patients were below the lower bound-
ary limit. For the IL-1 genotype negative patients, 2
were below the lower boundary and
1 was above the upper boundary of
the region of non-significance.
DISCUSSION
The aim of the present study was to
evaluate the effect of positive versus
negative genotype patients (IL-1
polymorphism) on bone level vari-
ations and on tooth loss following
periodontal therapy and long-term
maintenance. For these purposes,
60 consecutively selected peri-
odontal patients, treated and main-
tained on a 3-month recall program
for more than 10 years, were exam-
ined.
All 60 patients had the IL-1
genetic test in which 23 (38.3%) were genotype pos-
itive. These prevalence data are in accordance with
those of other studies.2,3,11-13
A recent study by McGuire and Nunn3 reported on
the influence of IL-1 polymorphism genotype within a
population treated and maintained long term. Their
data showed 47 teeth lost for periodontal reasons
(4.6%) in 42 patients, of which 27 (7%) were lost in
IL-1 genotype positive patients and 20 teeth (3%) in
IL-1 genotype negative patients. Unfortunately, given
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Table 3.
Teeth and Sites Excluded From the Study
Teeth (1,566) ∆BD Sites (3,132) ∆BC Sites (3,132)
Teeth lost to periodontitis 52 (3.32%)* 104 (3.32%) 104 (3.32%)
Restored teeth 127 (8.11%) 254 (8.11%) 254 (8.11%)
I CEJ-RAT0–CEJ-RAT2 I ≥5 mm 10 (0.64%) 20 (0.64%) 20 (0.64%)
Sites not detectable on radiographs 348 (11.11%) 351 (11.21%)
(CEJT0-2, RAT0-2, BDT0-2, BCT0-2)
N sites in 2 patients excluded 14 (0.45%) 14 (0.45%)
Remaining sites 2,392 (76.37%) 2,389 (76.28%)
* Based on number of teeth and sites at baseline.
Table 4.
Average Number of Sites Per Patient Used
for BD and BC Analysis (mean  SD)
IL-1 Negative IL-1 Positive 
N = 35 N = 23 P (t test)
N sites for ∆BD 41.77 + 7.79 40.43 ± 8.04 0.5306
analysis (25-54)* (21-54)
N sites for ∆BC 41.71 ± 7.80 40.39 ± 8.06 0.5353
analysis (25-54) (21-54)
* Minimum to maximum values.
Table 5.
Covariate Values of the Lower (XL) and
Upper Boundary (XU) of the Region of Non-
Significance in Relation to the Baseline
CEJ-BD and CEJ-BC Values
XL XU
CEJ-BDT0 (mm) 1.70 5.81
CEJ-BCT0 (mm) 2.00 5.52
Figure 2.
Scatter plot and regression lines for the variation of the bone defect
level (∆BD) for IL-1 genotype positive (+) and negative patients ().
------ = regression line IL-1 genotype negative.
......... = regression line IL-1 genotype positive.
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the differences in study design and population char-
acteristics (30 patients in the McGuire and Nunn
study3 were or had been smokers), it was impossible
to directly compare the results.
In the present investigation of 60 subjects, the per-
centage tooth loss overall was 3.3% (52 teeth); of
which 24 teeth were lost in IL-1 genotype positive
group and 28 teeth in IL-1 genotype negative group.
The mean tooth loss was not significantly different
between the 2 groups. Furthermore, the difference in
the average number of teeth requiring surgical inter-
vention per patient was not statistically significant by
genotype. Of the 36 patients who underwent surgery,
22 were genotype negative patients (59.5%) and 14
were genotype positive patients (60.9%). The mean
number of teeth surgically treated per patient was 7.00
and 7.96 for IL-1 genotype negative and positive
patients, respectively. This difference was not statisti-
cally significant. It should also be noted that surgery
was performed after initial therapy or sometime dur-
ing the maintenance period. The philosophy of the
periodontal practice was to perform surgery during
maintenance when one or more sites were not stable
in terms of probing depth or x-ray evaluation. More-
over, if bleeding on probing was evident at a recall
appointment, subgingival instrumentation was per-
formed under local anesthesia at those sites. If bleed-
ing on probing was still present at the following SPC
appointments, especially in previously unstable sites,
surgery was performed.
The data from our study referring to the initial bone
levels in positive and negative IL-1 genotype patients
indicate that the 2 groups of patients were initially
homogeneous since no statistical significance could
be demonstrated. This was surprising because one
would expect more destruction in the IL-1 positive
group. This could be related to the initial entry crite-
ria that probably rendered the 2 groups equivalent at
the beginning of the study.
As for the bone level variations radiographically
assessed at both T0 and T2, the results could be
affected by the measuring technique. However, the
preliminary reliability test was performed to assess the
intra- and inter-examiner reliability and it was accept-
able. In addition, the measurements were related to
the root length value in order to reduce the error due
to different radiographic projection and changes over
time such as root resorption. Some sites were excluded
because the reference points were not always
detectable due to new restorations (254); the inability
to locate radiographically the exact position of the CEJ,
root apex or bone defect (348); tooth extractions (104);
or differences between T0 and T2 measurements where
the |CEJ-RAT0 −1CEJ-RAT2| ≥5 mm (20). For the lat-
ter exclusion criterion, a threshold value of 5 mm was
chosen to avoid errors related to marked root resorp-
tions or different radiographic projections for which
the correction calculation would not report satisfac-
tory results. Our corrected absolute change allowed
us to use measurements in millimeters instead of in
percentage.
The Potthoff’s analysis revealed some unclear effects
of IL-1 polymorphism regarding the variation of the
bone levels in relation to the data at baseline, in the
few patients who were outside the region of non-sig-
nificance. In particular, IL-1 genotype negative patients
who showed minimal initial bone loss responded to
the therapy better than the IL-1 positive patients. How-
ever, IL-1 genotype positive patients with a severe ini-
tial bone loss showed a better response to the therapy
than IL-1 genotype negative patients. With this finding,
the genetic susceptibility testing in conjunction with
the information of initial bone loss profile (slight or
severe) seems to be particularly useful for prognostic
reasons at the beginning of therapy for predicting treat-
ment response.
Our population is obviously a group of patients who
are highly committed, compliant, and satisfied with
their therapy; however, the aim of our study was to
consider the differences between the IL-1 genotype
positive and negative patients who followed a metic-
ulous maintenance program. In addition, the genetic
evaluation was performed after all the dental measures
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Figure 3.
Scatter plot and regression lines for the variation of the bone crest level
(∆BC) for IL-1 genotype positive (+) and negative patients ().
- - - - = regression line IL-1 genotype negative.
......... = regression line IL-1 genotype positive.
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were recorded and the clinician was blinded to the
genetic results. The fact that the slope of the regres-
sion lines was different seems to indicate that peri-
odontal therapy is effectively different in the 2 groups,
especially for the extreme values of initial bone loss,
out of the region of non-significance. For intermediate
values, the therapy seems equally effective in the 2
groups.
However, in a study by De Sanctis and Zucchelli13
the authors evaluated the influence of the interleukin-
1 gene polymorphism on the long-term stability of
patients (8 smokers, 32 non-smokers) treated by
guided tissue regeneration (GTR). The results demon-
strated that genotype positive expression did not affect
the outcome of GTR treatment at 1 year, but had a
greater impact on long-term stability at 4 years. These
results seems to support the findings of another recent
study by Socransky et al.14 where the authors showed
that IL-1 genotype positive subjects more frequently
have higher levels of harmful species of bacteria that
are known to be strongly associated with periodontal
inflammation than IL-1 genotype negative subjects.
For this reason, the authors stated that strong man-
agement of the modifying factors with a more aggres-
sive therapy and a stringent maintenance protocol of
plaque control seem to be indicated in these high risk
individuals.
In conclusion, on average, there were no significant
differences by IL-1 genotype in tooth loss after 10
years in a non-smoking, well-maintained periodontal
population. On an individual patient basis, the IL-1
genotype, in combination with the initial bone level,
seems useful at the beginning of therapy for predict-
ing bone level variations.
ACKNOWLEDGMENT
The authors would like to acknowledge Nancy Whit-
ley for her help in reviewing the English language of
the manuscript.
REFERENCES
1. Hirschfeld L, Wasserman B. A long term survey of tooth
loss in 600 treated periodontal patients. J Periodontol
1978;49:225-237.
2. Kornman KS, Crane A, Wang HY, et al. The interleukin-
1 genotype as a severity factor in adult periodontal dis-
ease. J Clin Periodontol 1997;24:72-77.
3. McGuire MK, Nunn ME. Prognosis versus actual out-
come. IV. The effectiveness of clinical parameters and
interleukin-1 genotype in accurately predicting prog-
noses and tooth survival. J Periodontol 1999;70:49-56.
4. Fleiss JL. The Design and Analysis of Clinical Experi-
ments. New York: John Wiley & Sons; 1986:1-26.
5. Dunn G. Design and Analysis of Reliability Studies. The
Statistical Evaluation of Measurement Error. New York:
Oxford University Press; 1989:34-35.
6. Potthoff RF. On the Johnson-Neyman technique and
some extension thereof. Psychometrika 1964;29:241-
256.
7. Johnson DR, Neyman J. Tests of certain linear hypothe-
ses and their applications to some educational prob-
lems. Stat Res Memoirs 1936;1:57-93.
8. Huitema BE. The Analysis of Covariance and Alterna-
tives. New York: Wiley-Interscience Publication; 1980:
270-297.
9. Pedhazur EJ. Multiple Regression in Behavioral Research:
Explanation and Prediction, 3rd ed. Fort Worth: Harcourt
Brace College Publishers; 1997:591-603.
10. Rogosa D. Comparing nonparallel regression lines. Psy-
cholog Bull 1980;88:307-321.
11. Wilson TG Jr., Nunn ME. The relationship between the
interleukin-1 periodontal genotype and implant loss. Ini-
tial data. J Periodontol 1999;70:724-729. 
12. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin-
1 genetic association with periodontitis in clinical prac-
tice. J Periodontol 2000;71:156-163.
13. De Sanctis M, Zucchelli G. Interleukin-1 gene polymor-
phisms and long-term stability following guided tissue
regeneration therapy. J Periodontol 2000;71:606-613.
14. Socransky SS, Haffajee AD, Smith C. Microbiological
parameters associated with IL-1 gene polymorphisms
in periodontitis patients. J Dent Res 1999;78(Spec.
Issue):872(Abstr. 3600).
Send reprint requests to: Dr. Giovanpaolo Pini Prato, 11 Viale
Matteotti, 50121 Florence, Italy. Fax: 3955572881; e-mail:
gpinipr@tin.it
Accepted for publication January 4, 2001.
773
0189_IPC_AAP_553301  6/4/01  9:18 AM  Page 773
